E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression. Wang et al.

Published: 21 January 2022| Version 1 | DOI: 10.17632/gdcgx46ht8.1
Contributor:
Ying Liu

Description

This is the original data set for our study entitled "E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression"

Files

Institutions

Peking University

Categories

Life Sciences, Mammalian Target of Rapamycin, Ubiquitylation

License